Dose-response relationship and within-subject variability of insulin detemir and NPH insulin in subjects with type 1 diabetes

被引：0
|
作者：
Wutte, A
Plank, J
Sinner, F
Druml, T
Sommer, R
Zdravkovic, M
Ronn, BB
Draeger, E
Pieber, TR
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A152 / A152
页数：1
相关论文
共 50 条
  • [31] Dose-response of pulmonary insulin with the AERx® Insulin Diabetes Management System in healthy subjects
    Heise, T
    Scharling, B
    Bellaire, S
    Tusek, C
    Bott, S
    DIABETOLOGIA, 2001, 44 : A212 - A212
  • [32] SHORT-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH INSULIN IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES IN SWEDEN
    Ridderstrale, M.
    Ericsson, A.
    Jensen, M. M.
    VALUE IN HEALTH, 2011, 14 (07) : A480 - A480
  • [33] Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes - Response to Home et al.
    Kiess, W
    Raile, K
    Galler, A
    Kapellen, T
    DIABETES CARE, 2004, 27 (10) : 2567 - 2568
  • [34] Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus
    Thalange, Nandu
    Bereket, Abdullah
    Larsen, Jens
    Hiort, Line Conradsen
    Peterkova, Valentina
    PEDIATRIC DIABETES, 2011, 12 (07) : 632 - 641
  • [35] Lower rate of hypoglycaemia but comparable glycaemic control with insulin detemir compared to NPH insulin in patients with type 1 diabetes
    Hermansen, K.
    Heller, S.
    Andersen, M.
    Russell-Jones, D. L.
    DIABETOLOGIA, 2009, 52 : S359 - S359
  • [36] Insulin Detemir Reduces Hypoglycemic Risk at Comparable HbAfc Values Compared to NPH Insulin in Patients with Type 1 Diabetes
    Hermansen, Kjeld
    Heller, Simon
    Andersen, Marc
    Russell-Jones, David L.
    DIABETES, 2009, 58 : A529 - A530
  • [37] Within-person variation in fasting blood glucose is correlated to incidence of hypoglyacernia in people with Type 1 diabetes treated with insulin detemir and NPH insulin
    Heller, S
    Kim, H
    Draeger, E
    DIABETOLOGIA, 2004, 47 : A303 - A303
  • [38] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
    Buysman, E.
    Aagren, M.
    Liu, F.
    Bouchard, J.
    Conner, C.
    VALUE IN HEALTH, 2011, 14 (07) : A481 - A481
  • [39] Within-subject variability of inhaled insulin (Exubera®) versus subcutaneous regular insulin in elderly obese patients with Type 2 diabetes mellitus.
    Mudaliar, S
    Henry, RR
    Fryburg, DA
    Becker, RHA
    Willavize, SA
    Fisher, JM
    Fountaine, R
    Sha, S
    DIABETOLOGIA, 2003, 46 : A277 - A278
  • [40] Dose-Response Effects of Insulin Glargine in Type 2 Diabetes
    Wang, Zhihui
    Hedrington, Maka S.
    Joy, Nino Gogitidze
    Briscoe, Vanessa J.
    Richardson, M. Antoinette
    Younk, Lisa
    Nicholson, Wendell
    Tate, Donna B.
    Davis, Stephen N.
    DIABETES CARE, 2010, 33 (07) : 1555 - 1560
12345